Step Therapy for Prescription Drugs Balances Patient Safety and Cost Concerns

/, Letters to the Editor/Step Therapy for Prescription Drugs Balances Patient Safety and Cost Concerns

Step Therapy for Prescription Drugs Balances Patient Safety and Cost Concerns

A commentary by Paul Macielak, HPA president and CEO, examines problems with a bill awaiting action from Governor Cuomo that would restrict health plans use of “step therapy” policies. Published in Crain’s New York Business, October 10, 2016.

Read Online

2017-03-17T18:11:05+00:00 October 10th, 2016|All News, Letters to the Editor|